4 insiders reported 8 Form 4 transactions for NovaBridge Biosciences (NBP) over the past 18 months (most recent 2026-07-07). Recent activity: Xu Cong Claire (SVP, Clinical Development) Buy 12,432 shares, Xu Cong Claire (SVP, Clinical Development) Sell 4,485 shares, Dennis Phillip Andrew (Chief Medical Officer) Buy 23,695 shares, Dennis Phillip Andrew (Chief Medical Officer) Sell 8,494 shares, Xu Cong Claire (SVP, Clinical Development) Buy 9,382 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | Xu Cong Claire | SVP, Clinical Development | Buy | 12,432 | $0 |
| 2026-07-07 | Xu Cong Claire | SVP, Clinical Development | Sell | 4,485 | $3,992 |
| 2026-06-22 | Dennis Phillip Andrew | Chief Medical Officer | Buy | 23,695 | $0 |
| 2026-06-22 | Dennis Phillip Andrew | Chief Medical Officer | Sell | 8,494 | $5,606 |
| 2026-06-02 | Xu Cong Claire | SVP, Clinical Development | Buy | 9,382 | $0 |
| 2026-06-02 | Xu Cong Claire | SVP, Clinical Development | Sell | 3,494 | $13,766 |
| 2026-05-18 | Cao Sean Wuxiong | See Remarks | Sell | 21,399 | $42,584 |
| 2026-04-28 | Hagler Mark Arnold | See Remarks | Buy | 230,000 | $577,300 |
Source: SEC Form 4 filings · as of 2026-07-07